Aura Biosciences, Inc. Shares Outstanding
Aura Biosciences, Inc. (AURA) had Shares Outstanding of 103.48 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-11
- 2026-06-30: Shares outstanding (split-adjusted) 103.48M shares; Shares authorized (split-adjusted) 150.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 64.15M shares; Shares authorized (split-adjusted) 150.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 63.59M shares; Shares authorized (split-adjusted) 150.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 62.99M shares; Shares authorized (split-adjusted) 150.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 103.48M shares 10-Q · filed 2026-08-11 | 150.00M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 64.15M shares 10-Q · filed 2026-05-11 | 150.00M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 63.59M shares 10-Q · filed 2026-08-11 | 150.00M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 62.99M shares 10-Q · filed 2025-11-13 | 150.00M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 62.07M shares 10-Q · filed 2025-08-13 | 150.00M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 50.23M shares 10-Q · filed 2025-05-15 | 150.00M shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 50.00M shares 10-K · filed 2026-03-30 | 150.00M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 49.78M shares 10-Q · filed 2024-11-12 | 150.00M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 49.58M shares 10-Q · filed 2024-08-08 | 150.00M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 49.50M shares 10-Q · filed 2024-05-09 | 150.00M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 49.35M shares 10-K · filed 2025-03-24 | 150.00M shares 10-K · filed 2025-03-24 |
| 2023-09-30 | 38.22M shares 10-Q · filed 2023-11-09 | 150.00M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 38.09M shares 10-Q · filed 2023-08-09 | 150.00M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 37.80M shares 10-Q · filed 2023-05-11 | 150.00M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 37.77M shares 10-K · filed 2024-03-27 | 150.00M shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 29.28M shares 10-Q · filed 2022-11-10 | 150.00M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 29.27M shares 10-Q · filed 2022-08-11 | 150.00M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 29.22M shares 10-Q · filed 2022-05-12 | 150.00M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 29.21M shares 10-K · filed 2023-03-15 | 150.00M shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 442.72K shares 10-Q · filed 2021-11-24 | 470.18M shares 10-Q · filed 2021-11-24 |
| 2020-12-31 | 381.12K shares 10-K · filed 2022-03-23 | 232.70M shares 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |